| Name | Title | Contact Details |
|---|
Tom Ford Beauty is a luxury beauty brand founded in 2006 by designer Tom Ford in collaboration with The Estée Lauder Companies. The brand debuted with the iconic fragrance *Black Orchid*, which established its reputation for opulence and innovation. Tom Ford Beauty is recognized as the first true luxury beauty brand of the 21st century, focusing on sensuality, glamour, and high-end craftsmanship. The brand offers a wide range of luxury products, including fragrances, color cosmetics, and candles. Notable fragrances include the *Private Blend* collection, featuring best-sellers like *Tuscan Leather* and *Oud Wood*. The color cosmetics line, launched in 2011, includes luxurious lipsticks and other makeup items. Tom Ford Beauty targets affluent consumers seeking exclusivity and high-quality products, appealing to both men and women. Its flagship boutiques are located in prestigious areas such as Madison Avenue in New York City and London, catering to a global luxury clientele.
Russell Forest Products is a Hartselle, AL-based company in the Business Services sector.
Mcube Investment Technologies, LLC is a Plano, TX-based company in the Business Services sector.
Downeast Properties is a Blue Hill, ME-based company in the Business Services sector.
MedMira Inc., a biotechnology company, is engaged in the research, development, manufacture, and sale of rapid diagnostics and technology platforms. Its research is focused on specific areas of the diagnostics market, including rapid, point-of-care, and in vitro sectors. Its products include Reveal HIV, which detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal HP/Rapid H. Pylori antibody tests that detect helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection; Reveal TP, a rapid syphilis antibody test, which detects treponema pallidum (TP) antibodies; Multiplo, a line of multiplex tests that combines testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis in whole blood, serum, or plasma; and Miriad developer toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its rapid tests through a network of medical distributors and strategic business development partners with customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies. The company sells and distributes its products in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and the Middle East. MedMira Inc. has collaboration with National Research Council of Canada. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. operates as a subsidiary of Onsite Lab Holding AG.